Sign inJoin waitlistJoin the waitlist

Kathryn Nevel

Assistant Professor of Clinical Neurology · Indiana University School of Medicine

Credentials: · · ·

History

Indiana University School of Medicine
Present
Indiana University School of Medicine
Present

Memorial Sloan Kettering Cancer Center
2015–2016
Neurology
University of Virginia Medical Center
2012–2015
Indiana University School of Medicine
2008–2012

Research

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Journal of the National Comprehensive Cancer Network · 2023 · 181 citations
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
Journal of Clinical Oncology · 2025 · 90 citations
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Proceedings of the National Academy of Sciences of the United States of America · 2021 · 81 citations

Andrew Southerland
3 papers
Laurie Gutmann
3 papers
SK
Shannon Kilgore
3 papers
Adrienne Boire
2 papers
Chunkit Fung
2 papers
Darren Feldman
2 papers
David Schiff
2 papers
David Vaughn
2 papers
Elena Pentsova
2 papers
John Kincaid
2 papers
Justin Jordan
2 papers
Lawrence Einhorn
2 papers

Clinical trials

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Study chair · Recruiting · Phase 2
Healx Limited
2025–2028
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Site PI · Not yet recruiting · Phase 2
Nuvation Bio Inc.
2027–2032
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
Site PI · Recruiting · Phase 2
RTOG Foundation, Inc.
2025–2030
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Site PI · Recruiting · Phase 3
Nuvation Bio Inc.
2023–2030